Download PDF
intensiv 2019; 27(03): 153-155
DOI: 10.1055/a-0873-0348
CNE Schwerpunkt
Update Sepsis
© Georg Thieme Verlag KG Stuttgart · New York

SAPF – eine seltene, aber schwere Komplikation

Jasmin Arrich
,
Frank M. Brunkhorst
Further Information

Publication History

Publication Date:
07 May 2019 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Von der Sepsis-assoziierten Purpura fulminans sind überwiegend Kinder zwischen einem und drei Jahren und Jugendliche zwischen 16 und 18 Jahren betroffen. Eine frühe Diagnose ist auch deswegen so wichtig, damit die Wahrscheinlichkeit einer Amputation so gering wie möglich gehalten wird.

 

  • Literatur

  • 1 Nicolas P, Debonne JM. Infections à méningocoques. Maladies infectieuses. 2002
    PubMedGoogle Scholar
  • 2 European Commission. Rare diseases – what are they?. 2018 Online unter bit.ly/2U2P8X5 letzter Zugriff 05.03.2019
    PubMedGoogle Scholar
  • 3 Veldman A, Fischer D, Wong FY. et al. Human protein C concentrate in the treatment of Purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients. Crit Care 2010; 14 (04) R156
    CrossrefPubMedGoogle Scholar
  • 4 Contou D, Sonneville R, Canoui-Poitrine F. et al. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. Intensive Care Med 2018; 44 (09) 1502-11
    CrossrefPubMedGoogle Scholar
  • 5 Guelliot A. Note sur trois cas de purpusa infectieux foudroyant. Un Med Sci Nord-Est 1884; 8: 25
    Google Scholar
  • 6 Waterhouse R. A case of suprarenal apoplexy. The Lancet 177 (4566) 577-8
    Google Scholar
  • 7 Chalmers E, Cooper P, Forman K. et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child 2011; 96 (11) 1066-71
    CrossrefPubMedGoogle Scholar
  • 8 Darmstadt GL. Acute infectious Purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 1998; 15 (03) 169-83
    CrossrefPubMedGoogle Scholar
  • 9 Warner PM, Kagan RJ, Yakuboff KP. et al. Current management of Purpura fulminans: a multicenter study. J Burn Care Rehabil 2003; 24 (03) 119-26
    CrossrefPubMedGoogle Scholar
  • 10 Thomsen RW, Schoonen WM, Farkas DK. et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med 2009; 151 (08) 546-55
    Google Scholar
  • 11 Bisharat N, Omari H, Lavi I. et al. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43 (03) 182-6
    CrossrefPubMedGoogle Scholar
  • 12 Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78 (09) 1031-8
    CrossrefPubMedGoogle Scholar
  • 13 Foss Abrahamsen A, Hoiby EA, Hannisdal E. et al. Systemic pneumococcal disease after staging splenectomy for Hodgkin’s disease 1969–1980 without pneumococcal vaccine protection: a follow-up study 1994. Eur J Haematol 1997; 58 (02) 73-7
    PubMedGoogle Scholar
  • 14 Kyaw MH, Holmes EM, Toolis F. et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 119 (03) 276.e1-7
    CrossrefPubMedGoogle Scholar
  • 15 Ejstrud P, Kristensen B, Hansen JB. et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis 2000; 32 (05) 521-5
    CrossrefPubMedGoogle Scholar
  • 16 Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Robert Koch-Institut; 2015
    Google Scholar